Recently, the omega class glutathione transferase (GSTO1-1) inhibitor C1-27 has been demonstrated to regulate the release of IL-1β and IL-18 by deglutathionylating NEK7 in the NLRP3 inflammasome [172] and thus to protect against CRC formation [173]. This evidence concerns the gene NLRP3 and colorectal carcinoma.